Merendino Lauren
SEC insider (Form 3/4/5 filer). CIK 0001855298. Chief Commercial Officer at Day One Biopharmaceuticals, Inc. (DAWN). 26 reported Form 4/5 transactions since Sep 2024; latest on Apr 23, 2026. Located in BRISBANE, CA.
Companies Merendino Lauren has filed insider reports for
- Day One Biopharmaceuticals, Inc. (DAWN): Officer, Chief Commercial Officer
Merendino Lauren
CIK: 0001855298
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Day One Biopharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirect60.2K shares- - Feb 17, 2026DAWN
Day One Biopharmaceuticals, Inc.
SaleDirect5.8K shares at avg. $11.60$67K - Feb 15, 2026DAWN
Day One Biopharmaceuticals, Inc.
ExerciseDirect3.7K shares- - Feb 15, 2026DAWN
Day One Biopharmaceuticals, Inc.
ExerciseDirect3.2K shares- - Feb 15, 2026DAWN
Day One Biopharmaceuticals, Inc.
ExerciseDirect3.7K shares- - Feb 15, 2026DAWN
Day One Biopharmaceuticals, Inc.
ExerciseDirect4.6K shares- - Jan 30, 2026DAWN
Day One Biopharmaceuticals, Inc.
AwardDirectStock Option (right to buy Common Stock)
110K shares- - Jan 30, 2026DAWN
Day One Biopharmaceuticals, Inc.
AwardDirectRestricted Stock Units
74K shares- - Nov 17, 2025DAWN
Day One Biopharmaceuticals, Inc.
SaleDirect3.7K shares at avg. $8.91$33K - Nov 15, 2025DAWN
Day One Biopharmaceuticals, Inc.
ExerciseDirect3.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition | 60,157 | - | $0 | Direct |
| Feb 17, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Sale | 5,814 | $11.60 | $67,448 | Direct |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Exercise | 3,687 | - | $0 | Direct |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Exercise | 3,162 | - | $0 | Direct |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Exercise | 3,688 | - | $0 | Direct |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Exercise | 4,625 | - | $0 | Direct |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Award Stock Option (right to buy Common Stock) | 110,000 | - | - | Direct |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Award Restricted Stock Units | 74,000 | - | - | Direct |
| Nov 17, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Sale | 3,726 | $8.91 | $33,216 | Direct |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Exercise | 3,162 | - | - | Direct |
1-10 of 26 transactions